MLACP 2.0: An updated machine learning tool for anticancer peptide prediction
Anticancer peptides are emerging anticancer drug that offers fewer side effects and is more effective than chemotherapy and targeted therapy. Predicting anticancer peptides from sequence information is one of the most challenging tasks in immunoinformatics. In the past ten years, machine learning-ba...
Main Authors: | Le Thi Phan, Hyun Woo Park, Thejkiran Pitti, Thirumurthy Madhavan, Young-Jun Jeon, Balachandran Manavalan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037022003245 |
Similar Items
-
Capture of systemic anticancer therapy use by routinely collected health datasets
by: Hanna E Tervonen, et al.
Published: (2020-03-01) -
Accurately predicting anticancer peptide using an ensemble of heterogeneously trained classifiers
by: Sayed Mehedi Azim, et al.
Published: (2023-01-01) -
An Image-Based Benchmark Dataset and a Novel Object Detector for Water Surface Object Detection
by: Zhiguo Zhou, et al.
Published: (2021-09-01) -
Anticancer Activity of Bacterial Proteins and Peptides
by: Tomasz M. Karpiński, et al.
Published: (2018-04-01) -
Current update on anticancer effects of icariin
by: Mukta Gupta, et al.
Published: (2022-04-01)